Sham Ramdas Tupe

Title: Sham Ramdas Tupe: Innovator in Influenza Vaccine Development

Introduction

Sham Ramdas Tupe is a notable inventor based in Pune, Maharashtra, India. He has made significant contributions to the field of vaccine development, particularly in the area of influenza vaccines. His innovative work has the potential to enhance public health by providing effective protection against influenza virus infections.

Latest Patents

Sham Ramdas Tupe holds a patent for a "Stabilized live attenuated influenza vaccine compositions." This patent outlines compositions and methods for manufacturing a live attenuated influenza vaccine (LAIV) that can be delivered intranasally. The LAIV strains are based on cold-adapted, temperature-sensitive, and attenuated phenotypes of master donor viruses (MDVs). These strains contain the surface glycoprotein genes of wild-type pandemic or seasonal influenza strains. The innovative aspect of this vaccine is that it avoids the use of eggs in large-scale manufacturing and eliminates chromatography steps in the purification process. The LAIV composition includes one or more live attenuated influenza vaccine viruses and is devoid of polymers and surfactants.

Career Highlights

Sham Ramdas Tupe is associated with the Serum Institute of India Private Limited, a leading organization in vaccine production. His work at this esteemed institution has allowed him to contribute to the advancement of vaccine technology and public health initiatives.

Collaborations

Sham has collaborated with several professionals in his field, including Rajeev Mhalasakant Dhere and Leena Ravindra Yeolekar. Their combined expertise has likely enhanced the development and implementation of innovative vaccine solutions.

Conclusion

Sham Ramdas Tupe's contributions to the field of influenza vaccine development exemplify the importance of innovation in public health. His patented work on live attenuated influenza vaccines represents a significant advancement in vaccine technology.